atezolizumab

Ukraine

Drugs containing this active substance

  • TECENTRIQ

    The drug is prescribed for the treatment of various types of cancer, including non-small cell lung cancer (adjuvant treatment or treatment of metastatic cancer), small cell lung cancer, as well as hepatocellular carcinoma (liver cancer).

    Form: concentrate for infusion solution

    Active substance Dosage
    atezolizumab 1200 mg/20 ml

    ATC: L01FF05

    Manufacturer: Roche Diagnostics GmbH (manufacturing of unpackaged products, primary packaging, quality control testing)